Lidiya Bebrevska

A novel multiple-stage antimalarial agent that inhibits protein synthesis

Beatriz Baragaña, Irene Hallyburton, Neil R. Norcross et al. · Nature · 2015 · 452 citations · Full text

Antiparasitic Agent, Medicine, Malaria +4

Safety, tolerability, pharmacokinetics, and activity of the novel long-acting antimalarial DSM265: a two-part first-in-human phase 1a/1b randomised study

James McCarthy, Julie Lotharius, Thomas Rückle et al. · The Lancet Infectious Diseases · 2017 · 124 citations · Full text

In vivo antioxidative activity of a quantified Pueraria lobata root extract

Lidiya Bebrevska, Kenn Foubert, Nina Hermans et al. · Journal of Ethnopharmacology · 2009 · 92 citations

Vivo Antioxidative Activity, Botany, Biochemistry +7

Safety, tolerability, pharmacokinetics, and antimalarial efficacy of a novel Plasmodium falciparum ATP4 inhibitor SJ733: a first-in-human and induced blood-stage malaria phase 1a/b trial

Aditya H. Gaur, James McCarthy, John C. Panetta et al. · The Lancet Infectious Diseases · 2020 · 74 citations

Antiparasitic Agent, Medicine, Malaria +5

The antimalarial MMV688533 provides potential for single-dose cures with a high barrier to <i>Plasmodium falciparum</i> parasite resistance

James M. Murithi, Cécile Pascal, Jade Bath et al. · Science Translational Medicine · 2021 · 49 citations · Full text